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ABSTRACT
Paternal duplications of chromosome 6q24, a region
that contains the imprinted PLAGL1 and HYMAI
transcripts, are associated with transient neonatal
diabetes mellitus. A common feature of imprinted
genes is that they tend to cluster together, presum-
ably as a result of sharing common cis-acting regu-
latory elements. To determine the extent of this
imprinted cluster in human and mouse, we have
undertaken a systematic analysis of allelic expres-
sion and DNA methylation of the genes mapping
within an 1.4-Mb region flanking PLAGL1/Plagl1.
We confirm that all nine neighbouring genes are
biallelically expressed in both species. In human
we identify two novel paternally expressed PLAGL1
coding transcripts that originate from unique
promoter regions. Chromatin immunoprecipitation
for CTCF and the cohesin subunits RAD21 and
SMC3 reveals evolutionarily conserved binding
sites within unmethylated regions 5 kb down-
stream of the PLAGL1 differentially methylated
region and within the PLAGL1 30 untranslated
region (UTR). Higher-order chromatin looping
occurs between these regions in both expressing
and non-expressing tissues, forming a non-allelic
chromatin loop around the PLAGL1/Plagl1 gene. In
placenta and brain tissues, we identify an additional
interaction between the PLAGL1 P3/P4 promoters
and the unmethylated element downstream of the
PLAGL1 differentially methylated region that we
propose facilitates imprinted expression of these al-
ternative isoforms.
INTRODUCTION
Genomic imprinting is defined by genotype-independent
expression from either the maternal or paternal allele.
This parent-of-origin expression is mediated by epigenetic
modifications that differ between the two parental chromo-
somes (1). There are currently more than 60 imprinted
genes in humans, which are largely conserved in mouse
(2; http://igc.otago.ac.nz/home.html). Human diseases
associated with cytogenetic abnormalities or (epi)muta-
tions, such as transient neonatal diabetes mellitus
(TNDM) and Beckwith–Wiedemann, Silver–Russell,
Angelman and Prader–Willi syndromes, and targeted
mouse experiments have revealed that imprinted genes
are essential for foetal and postnatal growth and behav-
iour, with aberrant expression in adults associated with
multigenic diseases and cancer (3–8).
Imprinted genes are regulated by cis-acting imprinting
control regions (ICRs), which manifest as regions of allelic
DNA methylation that are set during gametogenesis and
are inherited throughout somatic development by the
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action of the DNMT1 complex (9–11). These differentially
methylated regions (DMRs) are associated with a canon-
ical chromatin signature, which comprises H3 lysine
9 trimethylation and H4 lysine 20 trimethylation on the
DNA-methylated allele, whereas H3 lysine 4 methylation
is associated with the unmethylated allele and may confer
protection from de novo DNA methylation (12).
Imprinted genes rarely occur in isolation, as monoallelic
expression is achieved by shared cis-regulatory elements
that act in distinct ways at different loci (reviewed in 1).
Despite information from a few well-studied loci, still little
is known how ICRs silence neighbouring genes, and there
seems to be two prevailing models of regulation. In
general, paternally methylated intergenic ICRs act as
methylation-sensitive insulators recruiting CTCF (13),
while the majority of maternally methylated ICRs act as
promoters. In some cases, these differentially methylated
promoters are associated with long non-coding RNAs that
confer silencing of neighbouring genes in cis through re-
cruitment of histone-remodelling complexes (14,15).
However, for the majority of imprinted domains, the
intricacies of ICR action are unknown, and novel mech-
anisms, such as allele-specific alternative polyadenylation
choice, are continuously updating our insight on
imprinted regulation (16). Imprinted domains are espe-
cially attractive to researchers as they permit the study
of inherited epigenetic transcriptional regulation, as both
the active and silent alleles are genetically identical and are
present within the same nucleus, exposed to the same
trans-acting chromatin regulators.
To date, the imprinted domain on human chromosome 6
associated with TNDM contains two paternally expressed
transcripts, PLAGL1 (previously known as ZAC1) and the
non-coding RNAHYMAI, both initiating from within the
maternally methylated PLAGL1-DMR (17,18). To deter-
mine whether these transcripts are part of a larger imprint-
ing cluster, we performed allelic expression analysis of the
flanking genes in both human and mouse. This revealed
that the region is a micro-imprinted domain, as all sur-
rounding transcripts are biallelically expressed in both
species, including PHACTR2, which we show exhibits
allelic bias in human placenta associated with genotype
and not parental origin (19). Interrogation of publicly
available CTCF ChIP-seq data shows that PLAGL1 is
flanked by CTCF-binding sites conserved between species
in both expressing and non-expressing cells. These two
CTCF/cohesin regions interact physically despite being
separated by more than 70 kb, and we propose this restricts




A cohort comprising 65 foetal tissue sets (8–18 weeks)
with corresponding maternal blood samples and 96 term
placental samples from the Moore Tissue bank are
described elsewhere (20). An additional 96 human
placenta samples were collected at Hospital St Joan De
Deu (Barcelona, Spain). DNA and RNA extraction and
cDNA synthesis were carried out as previously described
(21). A selection of normal adult brain samples was
obtained from BrainNet Europe/Barcelona Brain Bank.
The human RNA panel was purchased from Clontech
(Human Total RNA master Panel II). Ethical approval
for adult blood and foetal tissue collection was granted
by the Hammersmith, Queen Charlotte’s & Chelsea and
Acton Hospital Research Ethics Committee (Project
Registration 2001/6029 and 2001/6028); collection of the
HSJD placental cohort was granted by the ethical com-
mittee of Hospital St Joan De Deu (Study Number 35/07)
and IDIBELL (PR006/08). Written informed consent was
obtained from all participants.
Mouse crosses and cell lines
To determine allelic expression in mouse, wild-type
embryos and placentas were produced by crossing
C57BL/6 (B) with Mus musculus castaneus (C) mice.
RNA and DNA were isolated and extracted as previously
described (10). Control lymphoblastoid cell lines were
established by Epstein–Barr virus transformation of per-
ipheral blood cells and propagated as previously described
(22). Before chromatin immunoprecipitation (ChIP), the
lymphoblastoid methylation signature throughout the
PLAGL1 domain was compared with leucocytes to
ensure that the transformation process had not altered
the epigenetic profile. The human TCL1 placental tropho-
blast cell line was grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and
antibiotics.
Allelic expression analysis
Genotypes were obtained in the foetal and placental tissues
for expressed genes using PCR and direct sequencing.
Sequences were interrogated using Sequencher v4.6 (Gene
Codes Corporation, MI) to distinguish heterozygous and
homozygous samples. Heterozygous sample sets were
analysed for allelic expression using RT-PCR that
incorporated the polymorphisms in the final PCR
product (Supplementary Table S1). The resulting
RT-PCR amplicons were sequenced in both directions.
The amplification cycle number for each transcript was
determined to be within the exponential phase of the
PCR, which varied for each gene, but was between 32
and 40 cycles.
Pyrosequencing analysis for allelic expression
quantification
Pyrosequencing was used as an accurate method of quan-
tifying allelic expression of PHACTR2 in heterozygous
placenta samples. Standard RT-PCR was used to amplify
across two independent single nucleotide polymorphisms
(SNPs) mapping to exon 6 (an alternative spliced exon)
and the 30 UTR, with the exception that the reverse
primers were biotinylated. The entire biotinylated
RT-PCR product (diluted to 40 ml) was mixed with 38 ml
of binding buffer and 2 ml (10mg/ml) of streptavidin-coated
polystyrene beads. Bead–amplicon complexes were
captured on a vacuum prep tool (Qiagen), and the PCR
products denatured using 0.2M NaOH. The denatured
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DNA was resuspended in 40 pmol of sequencing primer
dissolved in 12 ml of water, and primer annealing was
achieved by heating the sample to 80C for 2 min before
cooling to room temperature. For sequencing, forward
primers were designed to the complementary strand
(Supplementary Table S1). The pyrosequencing reaction
was carried out on a PyroMark Q96 instrument. The
peak heights were determined using the pyrosequencing
commercial software.
Real-time RT-PCR
All PCR amplifications were run in triplicate on either an
Applied Biosystems 7500 or 7900 Fast real-time PCR
machines (Applied Biosystems) following the manufac-
turers’ protocol. All primers were optimized using SYBR
Green (Supplementary Table S1 for PLAGL1 primers, all
other genes were amplified using KiCqStart primers from
Sigma-Aldrich), and melt curve analysis was performed to
ensure that amplicons were specific and free of
primer-dimer products. Thermal cycle parameters
included Taq polymerase activation at 95C for 10min
for one cycle, repetitive denaturation at 95C for 15 s
and annealing at 60C for 1min for 40 cycles. All resulting
triplicate cycle threshold (Ct) values had to be within 1 Ct
of each other. The quantitative values for each triplicate
were determined as a ratio with the level of RPL19 expres-
sion, which was measured in the same sample.
Analysis of allelic DNA methylation
The DNA methylation profile throughout the PLAGL1
domain was determined using published data from our
previous Illumina Infinium HumanMethylation27
BeadChIP array analysis (GEO accession number: GSE
28525) (23). Promoter regions not included on this array
platform were assessed by conventional bisulphite PCR.
Approximately 1 mg of DNA was subjected to sodium
bisulphite treatment and purified using the EZ GOLD
methylation kit (ZYMO, Orange, CA) and was used for
all bisulphite PCR analysis. Bisulphite PCR primers for
each region were used with Hotstar Taq polymerase
(Qiagen, West Sussex, UK) at 45 cycles, and the resulting
PCR product was cloned into pGEM-T easy vector
(Promega) for subsequent sequencing (see
Supplementary Table S1).
Chromatin immunoprecipitation
We used previously published CTCF ChIP-seq data sets
for leucocytes and CD34 cells (GEO accession number:
GSM651541) and chromatin interaction analysis with
paired-end tags (ChIA-PET; GEO accession number:
GSM970213 and GSM970216) (http://dir.nhlbi.nih.gov/
papers/lmi/epigenomes/hgtcell.aspx) to identify potential
binding sites within the 6q24-imprinted domain. For
ChIP, chromatin from 80 million cells was aliquoted
into 100-mg batches and used for each immunopre-
cipitation reaction with Protein A Agarose/Salmon
Sperm DNA (Millipore, 16-157) and specific antibody.
The antibody against CTCF (07-729) was obtained from
Millipore, and the antibodies against RAD21 (AB992)
and SMC3 (AB9263) were obtained from ABCAM. For
each ChIP, a fraction of the input chromatin (1%) was
also processed for DNA purification, and a mock
immunoprecipitation with a neutral unrelated IgG anti-
serum was carried out in parallel.
Levels of immunoprecipitated chromatin at specific
region were determined by qPCR using an Applied
Biosystems 7900 Fast real-time PCR machine, using
SYBR Green (Applied Biosystems). Each PCR was run
in triplicate, and protein binding was quantified as a per-
centage of total input material. Normalization of ChIP
levels was performed by comparing precipitation levels
obtained for each specific region of interest with the
level obtained for a known CTCF/cohesin-positive
control region mapping to chromosome 6 (24) (see
Supplementary Table S1 for primer sequences).
Chromatin conformation capture analysis
The chromatin conformation capture (3C) protocol was
performed as previously described (25), with minor
amendments. Briefly, HindIII was used to digest 1 107
formaldehyde–cross-linked nuclei from leucocytes, placen-
tal cell line TCL1, mouse embryonic fibroblasts (MEFs)
(for which EcoR1 was used) or 100mg of archived tissue
(overnight digestion, 1200 U, NEB). The efficiency of the
restricted enzyme digestion was assessed by qPCR across
each restriction site, comparing digested and undigested
chromatin fractions. Only chromatin with digestion effi-
ciency more than 70% was used. Subsequently, the DNA
was ligated overnight in a 500-ul reaction volume using
1950 units of T4 ligase (Fermentas). DNA was de–
cross-linked by incubating overnight at 65C and
purified using phenol/chloroform extraction. This DNA
was used for both nested PCR for analysis of allelic inter-
actions, and real-time PCR (LightCycler, Roche Applied
Science) to determine the frequency of interactions, using
constant primers either in the unmethylated regions 5 kb
upstream from the DMR, within the last PLAGL1 exon,
or between the P3/P4 promoters (see Supplementary Table
S1). Primer efficiency and basal interaction frequencies
were determined using digested and ligated bacterial
artificial chromosomes (BAC) DNA (human RPII RP11
947A22; mouse RP24 399D18) as described by Braem and
co-workers (26). All 3C experiments were performed in at
least 3 biological samples per tissue in technical triplicates.
RESULTS
PLAGL1 and /HYMAI are the only imprinted genes
mapping to 6q24
To characterize the boundaries of the imprinted region on
human chromosome 6, we determined the abundance and
allele-specific expression of nine genes flanking PLAGL1
(DEADC1, PEX3, FUCA2, PHACTR2, LTV1, SF3B5,
STX11, BC033369/LOC285740 and UTRN) using
RT-PCR amplification across transcribed SNPs in first
trimester foetal tissues and term placenta. No SNPs were
identified within FAM164B. We confirm that human
PLAGL1 transcripts from the P1 promoter and HYMAI
were paternally expressed in all tissues analysed at all ges-
tational ages. The PLAGL1 expression from the P2
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promoter was biallelic when detectable. Biallelic expres-
sion of the remaining transcripts was observed in all
tissues analysed, and their associated promoters were
unmethylated (Figure 1A and B; Supplementary
Figures S1 and S2; Supplementary Table S2).
To assess the imprinting profile within the mouse
orthologous region on chromosome 10, we used various
embryonic tissues and placenta (at embryonic stage E14.5)
from reciprocal crosses between C57BL/6 (B) and Mus
musculus castaneus (C). We confirm the ubiquitous im-
printing previously described for the paternally expressed
Plagl1 transcript, and observed equal expression from
both parental alleles for all other genes (Supplementary
Figure S3).
Conserved paternally expressed PLAGL1 isoforms
We recently identified and characterized several paternally
expressed Plagl1 alternative transcripts in mouse (27)
(Figure 1C). One of these transcripts, originating from
the P3 promoter region, results in a transcript containing
the protein-coding exons. As a result of expressed sequence
tag (EST) and mRNA alignments, we identified an
orthologous transcript originating from the equivalent P3
promoter region in the human. This transcript (reference
EST AJ006354) originates from a unique promoter region
50 to the exon 6 acceptor site (tctcacag/GTTTGAAT or
tgtacaag/GTCTCTTC) of the P1-PLAGL1 transcript,
with a 50 UTR that extends at least 800 bp into the
upstream intron. In addition, we identified another tran-
script originating from a novel promoter region 3.5 kb
upstream of the P3 promoter, located 50 to the exon 5
acceptor site (ctttctag/GTATTTGC) of P1-PLAGL1 tran-
script, which we named P4-PLAGL1 (Figure 1C). The re-
sulting transcript (reference EST AK091707) also includes
the full open reading frame. Both of these promoter regions
can produce transcripts with alternative splicing of the pen-
ultimate exon, which results in protein lacking the first two
zinc finger domains. These transcripts are evident on the
northern blot analysis performed by Kas et al. (28) using a
probe encompassing last exon ofPLAGL1. Using strategic-
ally positioned RT-PCR primers, we were unable to link
these unique 50 UTRs with exons 1–3 of P1-PLAGL1, con-
firming that these are independent transcripts. Consistent
with this, we observe that P1-PLAGL1 expression was
higher than all other isoforms in a panel of foetal and
adult tissues (Supplementary Figure S4), with all tran-
scripts being most plentiful in placenta and absent in
leucocytes. Using an SNP located within exon 7, we show
that these novel isoforms are paternally expressed in
placenta (n=11) and monoallelically expressed in brain
(n=2) (Figure 1C and D).
Human PHACTR2 exhibits genotype-associated allelic
expression in placenta
Partial imprinting of PHACTR2 has been described in
some term placentas, with maternal bias observed for
the SNP rs1082 within the 30 UTR of the gene. The ex-
pression levels of PHACTR2 were reported to be lower in
heterozygous placentas compared with homozygous
samples, suggesting that the genotype could play a role
in the allelic bias (19). Using both standard Sanger
DNA sequencing and quantitative pyrosequencing, we
also observed a range of allelic profiles for rs1082, consist-
ent with previous reports. However, on assessing a second
SNP (rs2073214) within exon 6 of PHACTR2, three pla-
cental samples showed equal expression from both
parental alleles, whereas 17 had strong preferential/
monoallelic expression of the T allele. Subsequent
genotyping of maternal DNAs corresponding to these
samples identified two placentas with expression from
the paternal allele, revealing that the monoallelic expres-
sion observed is not due to imprinting but presumably
SNP-associated regulation (Supplementary Figure S5).
CTCF/cohesin form non-allelic boundaries
flanking PLAGL1
In an attempt to understand the mechanism restricting
imprinting to HYMAI and the PLAGL1 transcripts, we
interrogated genome-wide CTCF data sets to identify po-
tential CTCF boundaries. Using two published data sets
(29,30), we identified two regions of strong CTCF binding,
one 5 kb downstream of the PLAGL1-DMR and
between this and the non-imprinted P2 promoter, and
the other within the last exon of PLAGL1. This latter
region showed two independent CTCF peaks 2 kb
apart (Figures 1C and 2). Using PCR on bisulphite-con-
verted DNA, we were able to show that the CpG dinucleo-
tides surrounding these CTCF-binding sites are
unmethylated in leucocyte- and placenta-derived DNA
(Figure 2B). Comparison of the sequence surrounding
these binding sites identified CTCF consensus sites that
contain both motifs (M1 and M2) recently described by
Schmidt and co-workers (31). The M1 motifs of both
regions contain CpG dinucleotides, which ensure
methylation-sensitive binding. Interestingly, the second
binding site within the last PLAGL1 exon (region 6,
Figure 2) lacks the M2 motif and CpG dinucleotides
(data not shown).
Subsequent ChIP using antisera to CTCFwas performed
to confirm binding in lymphoblastoid cells and the placen-
tal cell line TCL1. We observed strong CTCF enrichment
within the regions downstream of the PLAGL1-DMR and
in the last exon, but not within the PLAGL1-DMR itself or
in the regions overlapping the P3 and P4 promoters
(Figure 2C; data not shown). Recently, cohesin has been
shown to play a critical role in maintaining CTCF
higher-order chromatin conformation at the H19-IGF2
loci (32). To determine whether CTCF and cohesin
co-localize within the PLAGL1 regions, we performed
ChIP using antisera against the cohesin subunits RAD21
and SMC3 (Figure 2C). In lymphoblastoiod cell lines, the
cohesin subunits clearly precipitated with CTCF on one
allele at theH19-ICR control region, and on both chromo-
somes throughout the PLAGL1 domain (Figure 2D).
The biallelic CTCF regions adjacent to PLAGL1
physically interact to form chromatin loops
Recent studies have revealed that CTCF is a key regulator
of chromatin fibre structure and responsible for
organizing chromosomal territories within the cell nucleus
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Figure 1. Schematic representation of the PLAGL1 domain on human chromosome 6p24. (A) The relative organization of the human genes and
CpG islands. The orthologous mouse domain has a similar organization, except the lack of the non-coding RNA LOC285740. (B) The allelic
expression for all genes in the human cluster. The sequence traces for heterozygous DNA samples from term placentas are shown for all genes, as
well as the resulting RT-PCR. Black boxes depict genes that are expressed biallelically in all tissues throughout gestation, whereas blue boxes
represent ubiquitously imprinted, paternally expressed transcripts. (C) A comparison of the structure and position of the imprinted transcripts within
the Plagl1/PLAGL1 transcriptional unit, including the location of the CTCF sites. (D) DNA sequences across rs2076684 SNP in the penultimate
PLAGL1 exon and the RT-PCR sequence traces for each isoform in term placenta.
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(33,34). To determine whether the CTCF/cohesin sites
physically interact, we performed 3C experiments to
identify potential chromatin folding. 3C-qPCR assays
were performed on adult leucocytes and brain samples,
term placenta material and the TCL1cell line, and inter-
action frequencies were determined between a constant
HindIII site located 500 bp upstream to the
unmethylated CTCF/cohesin binding site 50 to the
PLAGL1-DMR and other HindIII sites throughout the
locus. We observed high interaction frequencies of sites
separated by <20 kb from the constant fragment, which
included the PLAGL1-DMR, reflecting non-specific
random collision due to their physical proximity. We sub-
sequently identified strong interactions between the
CTCF/cohesin constant fragment and the CTCF/cohesin
sites in the last PLAGL1 exon, in different tissues irre-
spective of expression (Figure 3). Direct sequencing of
the chimerical products from placenta and brain
revealed that the interactions occurred on both chromo-
somes, and that the appropriate chimeric products result
from the 3C ligations (Figure 3D and Supplementary
Figure S6). Interrogation of publicly available
ChIA-PET (35) data revealed that CTCF mediates an
abundant loop identical to the one we identified
(Figure 3). In addition, we also identified non-allelic inter-
actions between the constant fragment and the HindIII
sites associated with the P3/P4 promoter regions in
placenta and brain (Figure 3B). We did not observe
these interactions in leucocytes, which suggests this
specific contact occurs only in tissues exhibiting transcrip-
tion from the P3/P4 promoters and appears independent
of CTCF binding. Interestingly, we observed a leucocyte-
specific chimeric product between the CTCF/cohesin
binding site 50 to the PLAGL1-DMR and a region in
intron 1, which may represent a repressive interaction.
These interactions were confirmed in two additional 3C
experiments using constant primers in the last PLAGL1
exon (Supplementary Figure S6) as well as the intervening
region between the P3 and P4 promoter (Figure 3C).
CTCF sites at conservation locations physically
interact in the mouse
Because the allelic expression patterns were similar
between human and mouse for genes surrounding
PLAGL1/Plagl1, we predicted that the higher-order chro-
matin structure will be comparable. Interrogation of the
Figure 2. DNA methylation and ChIP of CTCF, RAD21 and SMC3 analysis throughout the PLAGL1 locus. (A) The localization of the bisulphite
PCR and ChIP regions analysed. (B) Bisulphite sequence in placenta- and leucocyte-derived DNA. Each circle represents a single CpG dinucleotide
on the strand: (filled circle) a methylated cytosine, (open circle) unmethylated cytosines. (C) qPCR performed on CTCF, RAD21 and SMC3 ChIP
material in normal lymphoblastoid cells at various regions across the PLAGL1 domain. (D) Sequence traces showing monoallelic precipitation of
CTCF and cohesion subunits at the control H19-ICR domain and biallelic precipitation at region 6 mapping within the PLAGL1 30 UTR.
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mouse transcription factor binding site (TFBS) data set
from ENCODE (data available on the UCSC browser,
NCBI37/mm9 assembly) identified two regions of strong
CTCF binding at similar locations as in human (Figure 1).
To confirm that these sites interact to form a chromatin
loop, we performed allelic 3C on mouse embryonic fibro-
blast cells. This semi-quantitative analysis revealed a
biallelic contact between an EcoRI constant fragment con-
taining the CTCF site located 4 kb upstream of the
Plagl1-DMR and the binding site in the last exon
40 kb downstream (Supplementary Figure S7).
DISCUSSION
By analysing the allelic expression of transcripts flanking
PLAGL1/HYMAI, we show that this locus is one of only a
few true conserved micro-imprinted domains. Previously
reported micro-imprinted domains such as Grb10/GRB10
and imprinted transcripts that result from X-derived
retrotransposition into host gene introns have subse-
quently been shown to influence either neighbouring or
host genes (36–38).
We demonstrate that the imprinted transcriptional unit
in both humans and mouse is restricted within CTCF/
cohesin boundaries, suggesting that they are associated
with a conserved regulatory function. Interestingly, this
70-kb loop is very similar in size to the minimal TNDM
critical region identified by micro-duplications (39). By
using allelic 3C, we show that the flanking CTCF/
cohesin-binding sites physically interact in both species
in a biallelic manner. In humans, this confirmation is
maintained in both expressing and non-expression
tissues, suggesting that the chromatin architecture is main-
tained by CTCF/cohesin and that additional transcription
factors are required to promote expression. This is remin-
iscent of the CTCF/cohesin long-range interactions
observed at the IGF2-H19 domain in lymphoblastoid
cells, a cell type that does not express IGF2 despite main-
tained looping (22,32). In tissues that abundantly express
the predominant P1-PLAGL1 transcript, we identified
novel imprinted isoforms originating 45 kb downstream.
The promoter regions of the P3- and P4-PLAGL1 tran-
scripts are embedded within CpG-poor regions (the
upstream 1 kb of P3 and P4 have 12 and 10 CpG dinucleo-
tides, respectively). We hypothesize that the level of tran-
scription from these isoforms is regulated by a
combination of the endogenous promoter sequences and
shared enhancers with the P1-PLAGL1 promoter, the
latter conferring the allelic specificity. This is supported
by the observed CTCF-independent chromatin loop in ex-
pressed tissues that juxtaposes the P3/P4 promoters and
the PLAGL1-DMR so that any methylation-sensitive
transcription factor binding at the PLAGL1-DMR could
influence P3/P4 (Figure 4). Analysis of ChIA-PET using
Figure 3. Chromatin interactions with the CTCF sites upstream of the PLAGL1-DMR. (A) The position of the HindIII sites used for 3C analysis,
and annotated ChIA-PET data showing CTCF and POL2 interactions. (B) The looping profile in brain (black), placental TCL1 cell line (red) and
normal leucocytes (blue) using a constant primer 5 kb upstream of the PLAGL1-DMR, showing strong interactions with the 30 UTR and alternative
promoters of PLAGL1. The x-axis shows the position of the primers used. (C) The interaction profile in expressing tissues, brain (black) and
placental TCL1 cell line (red), using a constant primer between the P3 and P4 promoters. (D) Heterozygous SNP rs2064661 in constant fragment 5 kb
upstream of the PLAGL1-DMR allowed for allele-specific chromatin interactions to be assessed in adult brain. Sequence traces reveal biallelic
higher-order chromatin interactions between the constant fragment and various contact points throughout the PLAGL1 domain.
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CTCF and POL2 revealed that this second chromatin
interaction is solely present in the POL2 data set, confirm-
ing our observations (35).
A meta-analysis of microarray data recently revealed
that Plagl1 is a member of a co-regulated imprinted gene
network (IGN) important for embryonic growth (40). The
mechanism regulating this IGN remains to be elucidated,
and may be directly linked to the Plagl1 protein because it
encodes a zinc finger transcription factor (41).
Alternatively, it may be speculated that CTCF is a
common denominator mediating expression of numerous
imprinted loci via intra- and interchromosomal inter-
actions (42). Our results suggest that the TNDMphenotype
associated with paternal duplications of 6q24 likely results
from the overexpression of PLAGL1, the only imprinted
protein-coding gene in the region, and it remains to be
determined whether PLAGL1 is central to an IGN import-
ant for non-syndromic human growth as in mouse.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1 and 2 and Supplementary
Figures 1–7.
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